INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 7,376 Value ($000) $1 Avg Close — Range —
Q2 2024
Shares 3,668 Value ($000) $0 Avg Close — Range —
Q1 2024
Shares 3,353 Value ($000) $0 Avg Close — Range —
Q3 2023
Shares 8,122 Value ($000) $0 Avg Close — Range —
Q2 2023
Shares 6,751 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 5,490 Value ($000) $0 Avg Close — Range —
Q1 2021
Shares 9,216 Value ($000) $313 Avg Close — Range —
Q1 2020
Shares 14,043 Value ($000) $216 Avg Close — Range —
Q3 2019
Shares 41,823 Value ($000) $312 Avg Close — Range —
Q4 2018
Shares 12,449 Value ($000) $142 Avg Close — Range —
Q2 2018
Shares 48,594 Value ($000) $859 Avg Close — Range —
Q1 2018
Shares 44,194 Value ($000) $930 Avg Close — Range —
Q4 2017
Shares 111,100 Value ($000) $1,609 Avg Close — Range —
Q3 2016
Shares 14,100 Value ($000) $215 Avg Close — Range —
Q2 2016
Shares 25,068 Value ($000) $973 Avg Close — Range —
Q1 2016
Shares 7,300 Value ($000) $203 Avg Close — Range —